文献速递关节外科创伤骨科

关节腔内万古霉素粉末在大鼠关节内植入物污染模型中清除耐甲氧西林金黄色葡萄球菌

Intra-Articular Vancomycin Powder Eliminates Methicillin-Resistant S. aureus in a Rat Model of a Contaminated Intra-Articular Implant.
PubMed 文献 · J Bone Joint Surg Am · 2017-01-01

本研究在大鼠膝关节内植入物污染模型中比较四种抗生素方案,发现关节腔内万古霉素粉末联合全身万古霉素可完全清除耐甲氧西林金黄色葡萄球菌污染,而单用全身万古霉素则持续存在污染。

要点

  • 关节腔内万古霉素粉末联合全身万古霉素组骨、克氏针及整体动物培养阳性率均为0%。
  • 单用全身万古霉素组骨培养阳性率75%、克氏针63%、整体动物88%。
  • 仅联合用药组显示完全清除细菌污染的证据。

核心结论

  • 在大鼠关节内植入物污染模型中,关节腔内万古霉素粉末联合全身万古霉素完全清除了耐甲氧西林金黄色葡萄球菌污染。
  • 单用全身万古霉素的动物持续存在耐甲氧西林金黄色葡萄球菌污染。

研究设计与样本

  • 研究为动物实验,使用32只雌性Sprague-Dawley大鼠行膝关节切开术并植入股骨髓内钢丝,关节内接种1.5×10 CFU/mL耐甲氧西林金黄色葡萄球菌。
  • 动物分为四组:无抗生素对照组、术前全身万古霉素组、关节腔内万古霉素粉末组、全身万古霉素联合关节腔内万古霉素粉末组。
  • 术后第6天处死动物,取股骨远端骨、关节囊及植入钢丝行细菌学分析,统计采用Wilcoxon秩和检验和Fisher精确检验。

主要发现

  • 所有治疗组均无术后死亡、伤口并发症、万古霉素相关毒性或全身性疾病征象。
  • 联合用药组与单用全身万古霉素组相比,骨培养阳性率0% vs 75%(每组8只,p=0.007),克氏针培养阳性率0% vs 63%(每组8只,p=0.026),整体动物阳性率0% vs 88%(每组8只,p=0.01)。
  • 仅接受关节腔内万古霉素粉末联合全身万古霉素的动物显示完全清除细菌污染的证据。

关键数值与推荐

  • 骨培养阳性率:联合用药组0% vs 单用全身万古霉素组75%(每组8只,p=0.007)。
  • 克氏针培养阳性率:联合用药组0% vs 单用全身万古霉素组63%(每组8只,p=0.026)。
  • 整体动物阳性率:联合用药组0% vs 单用全身万古霉素组88%(每组8只,p=0.01)。

临床怎么用

  • 作者指出,本动物研究数据提示关节腔内万古霉素粉末用于降低假体周围关节感染风险应在临床研究中进一步调查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Periprosthetic joint infection following hip and knee arthroplasty leads to poor outcomes and exorbitant costs. Topical vancomycin powder has been shown to decrease infection in many procedures such as spine surgery. The role of vancomycin powder in the setting of total joint arthroplasty remains undefined. Our aim was to evaluate the efficacy of intra-articular vancomycin powder in preventing infection in a rat model of a contaminated intra-articular implant. METHODS: Thirty-two female Sprague-Dawley rats underwent knee arthrotomy and implantation of a femoral intramedullary wire with 1 mm of intra-articular communication. The knee joint was also inoculated with 1.5 × 10 colony forming units (CFU)/mL of methicillin-resistant Staphylococcus aureus (MRSA). Four treatment groups were studied: (1) no antibiotics (control), (2) preoperative systemic vancomycin, (3) intra-articular vancomycin powder, and (4) both systemic vancomycin and intra-articular vancomycin powder. The animals were killed on postoperative day 6, and distal femoral bone, joint capsule, and the implanted wire were harvested for bacteriologic analysis. Statistical analyses were performed using Wilcoxon rank sum and Fisher exact tests. RESULTS: There were no postoperative deaths, wound complications, signs of vancomycin-related toxicity, or signs of systemic illness in any of the treatment groups. There were significantly fewer positive cultures in the group that received vancomycin powder in combination with systemic vancomycin compared with the group that received systemic vancomycin alone (bone: 0% versus 75% of 8, p = 0.007; Kirschner wire: 0% versus 63% of 8, p = 0.026; whole animal: 0% versus 88% of 8, p = 0.01). Only animals that received both vancomycin powder and systemic vancomycin showed evidence of complete elimination of bacterial contamination. CONCLUSIONS: In a rat model of a contaminated intra-articular implant, use of intra-articular vancomycin powder in combination with systemic vancomycin completely eliminated MRSA bacterial contamination. Animals treated with systemic vancomycin alone had persistent MRSA contamination. CLINICAL RELEVANCE: This animal study presents data suggesting that the use of intra-articular vancomycin powder for reducing the risk of periprosthetic joint infections should be investigated further in clinical studies.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Edelstein AI, Weiner JA, Cook RW, et al. Intra-Articular Vancomycin Powder Eliminates Methicillin-Resistant S. aureus in a Rat Model of a Contaminated Intra-Articular Implant. J Bone Joint Surg Am. 2017. PMID: 28145954. doi:10.2106/JBJS.16.00127

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。